` ALBPS (Biophytis SA) vs DAX Index Comparison - Alpha Spread

ALBPS
vs
D
DAX Index

Over the past 12 months, ALBPS has underperformed DAX Index, delivering a return of -77% compared to the DAX Index's +20% growth.

Stocks Performance
ALBPS vs DAX Index

Loading
ALBPS
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ALBPS vs DAX Index

Performance Gap Between ALBPS and GDAXI
HIDDEN
Show

Performance By Year
ALBPS vs DAX Index

Loading
ALBPS
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Biophytis SA vs Peers

DAX Index
ALBPS
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Biophytis SA
Glance View

Market Cap
3.1m EUR
Industry
Biotechnology

Biophytis SA is a holding company. The company is headquartered in Paris, Ile-De-France and currently employs 24 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.

ALBPS Intrinsic Value
Not Available
Back to Top